Oral Supplementation of Gangliosides to Treat a Rare Metabolic Disorder

NCT02234024 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

DDC Clinic - Center for Special Needs Children